Cargando…

KCNQ5 Potassium Channel Activation Underlies Vasodilation by Tea

BACKGROUND/AIMS: Tea, produced from the evergreen Camellia sinensis, has reported therapeutic properties against multiple pathologies, including hypertension. Although some studies validate the health benefits of tea, few have investigated the molecular mechanisms of action. The KCNQ5 voltage-gated...

Descripción completa

Detalles Bibliográficos
Autores principales: Redford, Kaitlyn E., Rognant, Salomé, Jepps, Thomas A., Abbott, Geoffrey W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612027/
https://www.ncbi.nlm.nih.gov/pubmed/33667331
http://dx.doi.org/10.33594/000000337
_version_ 1784603406953873408
author Redford, Kaitlyn E.
Rognant, Salomé
Jepps, Thomas A.
Abbott, Geoffrey W.
author_facet Redford, Kaitlyn E.
Rognant, Salomé
Jepps, Thomas A.
Abbott, Geoffrey W.
author_sort Redford, Kaitlyn E.
collection PubMed
description BACKGROUND/AIMS: Tea, produced from the evergreen Camellia sinensis, has reported therapeutic properties against multiple pathologies, including hypertension. Although some studies validate the health benefits of tea, few have investigated the molecular mechanisms of action. The KCNQ5 voltage-gated potassium channel contributes to vascular smooth muscle tone and neuronal M-current regulation. METHODS: We applied electrophysiology, myography, mass spectrometry and in silico docking to determine effects and their underlying molecular mechanisms of tea and its components on KCNQ channels and arterial tone. RESULTS: A 1% green tea extract (GTE) hyperpolarized cells by augmenting KCNQ5 activity >20-fold at resting potential; similar effects of black tea were inhibited by milk. In contrast, GTE had lesser effects on KCNQ2/Q3 and inhibited KCNQ1/E1. Tea polyphenols epicatechin gallate (ECG) and epigallocatechin-3-gallate (EGCG), but not epicatechin or epigallocatechin, isoform-selectively hyperpolarized KCNQ5 activation voltage dependence. In silico docking and mutagenesis revealed that activation by ECG requires KCNQ5-R212, at the voltage sensor foot. Strikingly, ECG and EGCG but not epicatechin KCNQ-dependently relaxed rat mesenteric arteries. CONCLUSION: KCNQ5 activation contributes to vasodilation by tea; ECG and EGCG are candidates for future anti-hypertensive drug development.
format Online
Article
Text
id pubmed-8612027
institution National Center for Biotechnology Information
language English
publishDate 2021
record_format MEDLINE/PubMed
spelling pubmed-86120272021-11-24 KCNQ5 Potassium Channel Activation Underlies Vasodilation by Tea Redford, Kaitlyn E. Rognant, Salomé Jepps, Thomas A. Abbott, Geoffrey W. Cell Physiol Biochem Article BACKGROUND/AIMS: Tea, produced from the evergreen Camellia sinensis, has reported therapeutic properties against multiple pathologies, including hypertension. Although some studies validate the health benefits of tea, few have investigated the molecular mechanisms of action. The KCNQ5 voltage-gated potassium channel contributes to vascular smooth muscle tone and neuronal M-current regulation. METHODS: We applied electrophysiology, myography, mass spectrometry and in silico docking to determine effects and their underlying molecular mechanisms of tea and its components on KCNQ channels and arterial tone. RESULTS: A 1% green tea extract (GTE) hyperpolarized cells by augmenting KCNQ5 activity >20-fold at resting potential; similar effects of black tea were inhibited by milk. In contrast, GTE had lesser effects on KCNQ2/Q3 and inhibited KCNQ1/E1. Tea polyphenols epicatechin gallate (ECG) and epigallocatechin-3-gallate (EGCG), but not epicatechin or epigallocatechin, isoform-selectively hyperpolarized KCNQ5 activation voltage dependence. In silico docking and mutagenesis revealed that activation by ECG requires KCNQ5-R212, at the voltage sensor foot. Strikingly, ECG and EGCG but not epicatechin KCNQ-dependently relaxed rat mesenteric arteries. CONCLUSION: KCNQ5 activation contributes to vasodilation by tea; ECG and EGCG are candidates for future anti-hypertensive drug development. 2021-03-06 /pmc/articles/PMC8612027/ /pubmed/33667331 http://dx.doi.org/10.33594/000000337 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND). Usage and distribution for commercial purposes as well as any distribution of modified material requires written permission.
spellingShingle Article
Redford, Kaitlyn E.
Rognant, Salomé
Jepps, Thomas A.
Abbott, Geoffrey W.
KCNQ5 Potassium Channel Activation Underlies Vasodilation by Tea
title KCNQ5 Potassium Channel Activation Underlies Vasodilation by Tea
title_full KCNQ5 Potassium Channel Activation Underlies Vasodilation by Tea
title_fullStr KCNQ5 Potassium Channel Activation Underlies Vasodilation by Tea
title_full_unstemmed KCNQ5 Potassium Channel Activation Underlies Vasodilation by Tea
title_short KCNQ5 Potassium Channel Activation Underlies Vasodilation by Tea
title_sort kcnq5 potassium channel activation underlies vasodilation by tea
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612027/
https://www.ncbi.nlm.nih.gov/pubmed/33667331
http://dx.doi.org/10.33594/000000337
work_keys_str_mv AT redfordkaitlyne kcnq5potassiumchannelactivationunderliesvasodilationbytea
AT rognantsalome kcnq5potassiumchannelactivationunderliesvasodilationbytea
AT jeppsthomasa kcnq5potassiumchannelactivationunderliesvasodilationbytea
AT abbottgeoffreyw kcnq5potassiumchannelactivationunderliesvasodilationbytea